Pacira Pharmaceuticals Inc. develops, produces, and sells products used in hospitals and surgery centers.
The following data (in thousands) were adapted from recent financial statements.

1. Compute the monthly cash expenses for Years 1 and 2. Round to nearest thousand.
2. Compute the ratio of cash to monthly cash expenses for Years 1 and 2.
3. Including short-term investments as part of cash and cash equivalents, compute the ratio of cash to monthly cash expenses for Years 1 and 2. Round to one decimal place.
4. Comment on the results from parts (2) and (3).
5. Pacira had negative cash flows from operations for Years 1 and 2, yet cash, cash equivalents, and short-term investments increased from $27,447 in Year 1 to $77,452 ($47,467 + $29,985) in Year 2. How could this havehappened?

Transcribed Image Text:

Year 2 Year 1 Net cash flows from operating activities S(1,000 $(24,880) End of the year cash and cash equivalents 47467 Short-term investments Indudes various short-term securities that are readiły convertible to cash 27447 29,985